gavreto
roche registration gmbh - pralsetinib - karcinoma, nesīkšūnu plaušas - antineoplastiski līdzekļi - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
lunsumio
roche registration gmbh - mosunetuzumab - limfoma, folikulāra - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmoloģiskie līdzekļi - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
seedron®
adama - šķīstošs koncentrāts - fludioksonils + tebukonazols - citi produkti
clean me (2019.) pulveris
gadot biochemical industries ltd. - pulveris
hydro forte (2019.) pulveris, -
gadot biochemical industries ltd. - pulveris, -
sport&joints elektrolĪti + sĀls (2019.) pulveris
gadot biochemical industries ltd. - pulveris
biomg dead sea + vit b6 and b12 (2019.) pulveris
gadot biochemical industries ltd. - pulveris
biomagnesium forte (2018.) pulveris
gadot biochemical industries ltd. - pulveris